Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma (RAD001)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Susan Chang, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00823459
First received: January 13, 2009
Last updated: February 16, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)